Antihistamine
WITHDRAWN · PHASE3 · Irritable Bowel Syndrome, Dermatographism, Post-prandial Diarrhea
no funding for clinical research space
Registry sourceScientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.
Detailed evidence is available in the local Pro plan simulation.